Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

670
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
670
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

599
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
599
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

929
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
929
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.2K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency Department-initiated standard versus high-dose buprenorphine induction (ENVISION): a randomised clinical trial protocol.

BMJ open·2026
Same author

Special Considerations for Navigating the Institutional Review Board Process.

Journal of emergency nursing·2026
Same author

N-Acetylcysteine Dose and Treatment Duration in High-Risk Acetaminophen Ingestions Treated Within Eight Hours: A Retrospective Cohort Study.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial.

JAMA·2026
Same author

Evaluating the Predictive Validity of the Fordham Risk Screening Tool (FRST) for Violent Behavior during Inpatient Psychiatric Hospitalization.

Community mental health journal·2025
Same author

Risk Estimates of Five Adverse Outcomes Following Hip and Spine Surgery Among Children with Cerebral Palsy to Inform Peri-operative Care.

Journal of the Pediatric Orthopaedic Society of North America·2025

Related Experiment Video

Updated: Nov 23, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

652

Understanding ED Buprenorphine Initiation for Opioid Use Disorder: A Guide for Emergency Nurses.

Tania D Strout, Michael R Baumann, Lauren T Wendell

    Journal of Emergency Nursing
    |January 4, 2021
    PubMed
    Summary

    Opioid use disorder (OUD) is a major health crisis. Emergency nurses can improve care by initiating buprenorphine therapy, a key medication for OUD, and supporting patients through withdrawal.

    Keywords:
    BuprenorphineEmergency departmentEmergency nursingOpiate substitution treatmentOpioid-related disorders

    More Related Videos

    Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5
    10:49

    Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

    Published on: February 14, 2022

    4.0K
    Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
    11:02

    Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

    Published on: December 1, 2023

    1.3K

    Related Experiment Videos

    Last Updated: Nov 23, 2025

    Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
    04:13

    Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

    Published on: September 27, 2024

    652
    Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5
    10:49

    Murine Neural Plate Targeting by In Utero Nano-Injection NEPTUNE at Embryonic Day 7.5

    Published on: February 14, 2022

    4.0K
    Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
    11:02

    Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

    Published on: December 1, 2023

    1.3K

    Area of Science:

    • Public Health
    • Emergency Medicine
    • Pharmacology

    Background:

    • Opioid use disorder (OUD) presents a significant global public health challenge.
    • Medication-assisted treatment, particularly buprenorphine, is crucial for managing OUD.
    • Emergency departments serve as vital access points for individuals with OUD.

    Purpose of the Study:

    • To provide a comprehensive clinical review of OUD and opioid withdrawal syndrome.
    • To outline medication treatments for OUD, focusing on buprenorphine.
    • To detail best practices for emergency department (ED)-initiated buprenorphine therapy.

    Main Methods:

    • Clinical review of current literature and guidelines.
    • Discussion of assessment tools for opioid withdrawal.
    • Examination of discharge planning and special population considerations.

    Main Results:

    • Initiation of buprenorphine in the ED is increasing.
    • Emergency nurses require updated knowledge for effective patient care.
    • Nurses can advocate for destigmatization and improved treatment access.

    Conclusions:

    • Enhanced understanding of OUD, withdrawal, and treatments empowers emergency nurses.
    • ED-initiated buprenorphine can be a life-saving intervention.
    • Emergency nurses play a key role in public health advocacy for OUD patients.